Literature DB >> 17204028

Tumour budding in colorectal carcinoma.

F Prall1.   

Abstract

The term tumour budding denotes that at the invasion front of colorectal adenocarcinomas tumour cells, singly or in small aggregates, become detached from the neoplastic glands. This morphological feature is increasingly being recognized as a strong and robust adverse prognostic factor. Biologically, tumour budding is closely related to the epithelial-mesenchymal transition. In this review the morphological features of tumour budding are discussed, as observed by the surgical pathologist reporting colorectal carcinoma resection specimens. The morphological features are put into context with the rapidly expanding knowledge of the epithelial-mesenchymal transition in general, and the molecular pathology of colorectal carcinoma in particular. Finally, a systematic analysis of the relevant published clinicopathological studies emphasizes the potential of tumour budding as a prognostic factor for routine surgical pathology.

Entities:  

Mesh:

Year:  2007        PMID: 17204028     DOI: 10.1111/j.1365-2559.2006.02551.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  118 in total

1.  Microenvironmental interactions and expression of molecular markers associated with epithelial-to-mesenchymal transition in colorectal carcinoma.

Authors:  Sun-Jae Lee; Chun-Seok Yang; Dae-Dong Kim; Yu-Na Kang; Sang Gyu Kwak; Jae-Bok Park; Chang-Ho Cho; Kwan-Kyu Park
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy.

Authors:  Marianne Huebner; Bruce G Wolff; Thomas C Smyrk; Jeremiah Aakre; David W Larson
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

3.  The impact of expressions of CD97 and its ligand CD55 at the invasion front on prognosis of rectal adenocarcinoma.

Authors:  Shao-Liang Han; Chang Xu; Xiu-Ling Wu; Jun-Lin Li; Zhi Liu; Qi-Qiang Zeng
Journal:  Int J Colorectal Dis       Date:  2010-03-26       Impact factor: 2.571

4.  Comments on the reporting of lymph nodes and tumour budding in the checklist of colorectal carcinoma.

Authors:  Paolo Greco; Gaetano Magro
Journal:  Virchows Arch       Date:  2007-01-30       Impact factor: 4.064

5.  Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.

Authors:  Nobuyuki Ohike; Ipek Coban; Grace E Kim; Olca Basturk; Takuma Tajiri; Alyssa Krasinskas; Sudeshna Bandyopadhyay; Toshio Morohoshi; Yuki Shimada; David A Kooby; Charles A Staley; Michael Goodman; N Volkan Adsay; Nazmi Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

6.  Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers.

Authors:  Tsuyoshi Konishi; Yoshifumi Shimada; Lik Hang Lee; Marcela S Cavalcanti; Meier Hsu; Jesse Joshua Smith; Garrett M Nash; Larissa K Temple; José G Guillem; Philip B Paty; Julio Garcia-Aguilar; Efsevia Vakiani; Mithat Gonen; Jinru Shia; Martin R Weiser
Journal:  Am J Surg Pathol       Date:  2018-06       Impact factor: 6.394

Review 7.  Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer.

Authors:  Nicole Vincent Jordan; Gary L Johnson; Amy N Abell
Journal:  Cell Cycle       Date:  2011-09-01       Impact factor: 4.534

8.  Dioxin receptor expression inhibits basal and transforming growth factor β-induced epithelial-to-mesenchymal transition.

Authors:  Eva M Rico-Leo; Alberto Alvarez-Barrientos; Pedro M Fernandez-Salguero
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

Review 9.  Cell plasticity and heterogeneity in cancer.

Authors:  Nemanja D Marjanovic; Robert A Weinberg; Christine L Chaffer
Journal:  Clin Chem       Date:  2012-12-06       Impact factor: 8.327

10.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.